Plasmodium falciparum heme detoxification and hemoglobin degradation pathway (PfHeme-HGD)

The Plasmodium falciparum heme detoxification and hemoglobin degradation pathway is a vital metabolic process occurring within the parasite's acidic food vacuole during its intraerythrocytic stage. The parasite ingests host hemoglobin and enzymatically degrades it using proteases such as plasmepsins and falcipains to release essential amino acids required for its growth (Goldberg, 2005, PMID: 16102215). A byproduct of this process is the release of free heme (ferriprotoporphyrin IX), which is highly toxic to the parasite as it induces oxidative stress and membrane damage. To survive, the parasite detoxifies heme by sequestering it into an insoluble, chemically inert crystalline form known as hemozoin, a process often facilitated by parasite proteins like Histidine-Rich Protein 2 (Sullivan, 2002, PMID: 12435805). This pathway is the primary target for many classic antimalarial drugs, including chloroquine and other quinolines, which bind to heme and prevent its crystallization, thereby poisoning the parasite with its own metabolic waste (Egan, 2008, PMID: 18605768). Additionally, artemisinin-based compounds are thought to be activated by the heme iron within this pathway, leading to the formation of lethal free radicals (Tilley et al., 2016, PMID: 26769549).

Other names

Hemozoin formation pathwayHemoglobin digestion pathwayHeme crystallizationPlasmodium falciparum histidine-rich protein 2 (PfHRP2)Plasmepsin-mediated hemoglobin degradationFalcipain-mediated proteolysis

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free ferriprotoporphyrin IX; inhibition of hemoglobin-degrading proteases (plasmepsins and falcipains); and generation of free radicals through interaction with heme iron.